IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TINCANI, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.591
EU - Europa 19.046
AS - Asia 15.460
SA - Sud America 3.555
AF - Africa 370
OC - Oceania 68
Continente sconosciuto - Info sul continente non disponibili 44
Totale 71.134
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.141
CN - Cina 5.437
SG - Singapore 4.747
IT - Italia 4.658
UA - Ucraina 3.990
DE - Germania 3.332
BR - Brasile 2.981
HK - Hong Kong 2.284
PL - Polonia 1.817
FI - Finlandia 1.026
RU - Federazione Russa 1.009
VN - Vietnam 987
GB - Regno Unito 917
TR - Turchia 696
IE - Irlanda 690
FR - Francia 667
IN - India 370
AR - Argentina 234
SE - Svezia 220
CA - Canada 216
BD - Bangladesh 200
NL - Olanda 163
MX - Messico 152
ES - Italia 138
ZA - Sudafrica 108
ID - Indonesia 103
IQ - Iraq 102
EC - Ecuador 95
MA - Marocco 87
JP - Giappone 84
AT - Austria 63
CO - Colombia 61
AU - Australia 58
PK - Pakistan 47
VE - Venezuela 45
IL - Israele 42
BE - Belgio 41
EG - Egitto 41
EU - Europa 41
PY - Paraguay 41
UZ - Uzbekistan 41
SA - Arabia Saudita 40
CL - Cile 39
CZ - Repubblica Ceca 36
CH - Svizzera 33
RO - Romania 32
UY - Uruguay 31
JO - Giordania 29
LT - Lituania 28
TN - Tunisia 27
KE - Kenya 26
KZ - Kazakistan 26
EE - Estonia 24
DZ - Algeria 23
NP - Nepal 22
GR - Grecia 21
LB - Libano 21
AE - Emirati Arabi Uniti 20
IR - Iran 20
KR - Corea 20
AL - Albania 17
AZ - Azerbaigian 16
JM - Giamaica 16
DK - Danimarca 15
PE - Perù 14
PT - Portogallo 14
HU - Ungheria 13
PH - Filippine 13
SK - Slovacchia (Repubblica Slovacca) 13
TH - Thailandia 13
DO - Repubblica Dominicana 12
MU - Mauritius 12
BO - Bolivia 11
MK - Macedonia 11
TT - Trinidad e Tobago 11
BG - Bulgaria 10
CR - Costa Rica 10
ET - Etiopia 10
TW - Taiwan 10
SN - Senegal 9
HN - Honduras 8
LU - Lussemburgo 8
MY - Malesia 8
NO - Norvegia 8
PA - Panama 8
LV - Lettonia 7
PS - Palestinian Territory 7
RS - Serbia 7
BH - Bahrain 6
GE - Georgia 6
KG - Kirghizistan 6
AM - Armenia 5
BS - Bahamas 5
BY - Bielorussia 5
KW - Kuwait 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
OM - Oman 5
BW - Botswana 4
CI - Costa d'Avorio 4
Totale 71.062
Salva come PNG Salva come JPEG
Città #
Fairfield 4.277
Woodbridge 3.986
Jacksonville 2.810
Houston 2.730
Ashburn 2.332
Hong Kong 2.263
Singapore 2.235
Warsaw 1.798
Ann Arbor 1.736
Cambridge 1.638
Seattle 1.636
Wilmington 1.514
Princeton 1.213
Beijing 1.207
Nanjing 930
Chandler 752
New York 627
Dublin 625
Istanbul 568
Los Angeles 485
Helsinki 483
The Dalles 464
Milan 416
Nanchang 353
Ho Chi Minh City 339
Buffalo 300
Des Moines 300
São Paulo 271
Moscow 263
Shenyang 251
Munich 246
San Diego 234
Changsha 233
Hebei 230
Rome 209
Brescia 205
Hanoi 198
Dallas 193
Redondo Beach 191
Tianjin 169
Shanghai 153
Jiaxing 148
Lancaster 137
London 134
San Francisco 134
Jinan 130
Chicago 129
Verona 120
Florence 113
Nürnberg 102
Rio de Janeiro 99
Hangzhou 93
Kunming 88
Turku 79
Santa Clara 74
Guangzhou 69
Tokyo 67
Nuremberg 65
Toronto 62
Belo Horizonte 61
Dearborn 60
Turin 59
Zhengzhou 59
Johannesburg 58
Brooklyn 56
Chennai 56
Trieste 55
Bologna 53
Porto Alegre 53
Boardman 52
Lanzhou 51
Ningbo 50
Kocaeli 49
Phoenix 49
Brasília 47
Dong Ket 47
Curitiba 46
Dhaka 46
Mexico City 46
Montreal 42
Haiphong 41
Atlanta 40
Mumbai 40
Barcelona 39
Bergamo 39
Brussels 39
Council Bluffs 39
Taizhou 39
Genoa 38
Poplar 38
Baghdad 37
Da Nang 37
Udine 37
Orem 36
Paris 36
Salvador 36
Tashkent 36
Goiânia 35
Haikou 35
Stockholm 35
Totale 44.753
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.330
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.758
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). 1.285
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 318
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 284
Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients. 283
Abatacept reduces levels of switched memory B cells, autoantobodies, and immunoglobulins in patients with Rheumatoid Arthritis 277
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 272
The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation 237
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. 234
Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction? 233
Preface. What's New in Autoimmunity: New Autoantibodies, New Therapies, New Diseases 228
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. 216
Long-term outcome of children of rheumatic disease patients 214
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 212
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 211
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 199
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 198
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 190
Antirheumatic drugs and reproduction in women and men with chronic arthritis. 188
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome 187
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 185
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 184
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 183
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 182
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 180
Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage 177
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 177
Failure of intravenous immunoglobulin to prevent congenital heartblock: Findings of a multicenter, prospective, observational study 176
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 174
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends 173
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 173
Effect of short-term treatment with lercanidipine on circulating endothelial progenitor cells and structural alterations in retinal arterioles 172
Anti-phospholipid antibodies 171
Children born to SLE and APS mothers 171
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 168
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 167
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 167
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 167
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. 166
Typing TREX1 Gene In Patients With Systemic Lupus Erythematosus. 165
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 165
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 163
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 161
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. 160
A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus 159
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 158
Effetto del trattamento a breve termine con lercanidipina sulle cellule progenitrici endoteliali circolanti e sulle alterazioni strutturali delle arteriole retiniche 157
Management of thrombotic and obstetric antiphospholipid syndrome: A systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults 157
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 155
25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. 154
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 154
Antiphospholipid antibodies mediate autoimmunity against dying cells. 154
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 153
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 153
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 153
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 152
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 151
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 151
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 151
Autoimmune polyendocrine Syndromes 149
New acquirements on an old molecule: type I interferon. 149
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 149
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 147
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 147
Inflammatory molecules: A target for treatment of systemic autoimmune diseases. 146
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 146
Forum interdisciplinare per la ricerca delle malattie autoimmuni (FIRMA) study group. Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. 145
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 145
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 145
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 144
Pregnancy complications of the antiphospholipid syndrome 143
Beyond the "syndrome": antiphospholipid antibodies as risk factors. 143
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 143
State of the art: Reproduction and pregnancy in rheumatic diseases. 143
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 143
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 143
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 142
APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking. 142
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 142
Neuropsychological development of children born to patients with systemic lupus erythematosus 141
Impact of in utero environment on the offspring of lupus patients 141
Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension 141
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 141
V meeting of the European forum on antiphospholipid antibodies. 140
PROSPECTIVELY FOLLOWED PREGNANCIES IN PATIENTS WITH SYSTEMIC VASCULITIS: STILL MANY PROBLEMS ON BOTH FOETAL AND MATERNAL SIDE 139
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D 139
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 139
Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a 'systemic disease'. 138
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 138
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 137
Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? 137
Are the current attempts at standardization of antiphospholipid antibodies still useful? Emerging technologies signal a shift in direction. 137
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 137
RELATIONSHIP BETWEEN MICROVASCULAR T REGULATORY LYMPHOCYTES AND CIRCULATING LYMPHOCYTES 137
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 136
Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. 135
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 135
LA PREDITTIVITA DEGLI ANTICORPI ANTI-RO/SSA-P200 NEL BLOCCO CARDIACO CONGENITO 135
Management of recurrent thrombosis in antiphospholipid syndrome 135
Totale 21.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 332.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 332.002
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.860 0 0 0 0 0 1.117 312 1.083 1.149 949 886 364
2021/20225.224 279 978 159 312 145 300 317 393 289 556 468 1.028
2022/20233.583 701 46 82 180 281 995 41 288 517 54 206 192
2023/20244.334 235 124 327 346 191 637 156 180 1.244 108 90 696
2024/202510.258 141 131 102 1.184 1.088 918 934 405 866 1.148 2.099 1.242
2025/202611.467 1.792 2.881 1.666 3.190 1.738 200 0 0 0 0 0 0
Totale 71.990